Malaria
Genetic variation protects against two types
Published in TB and Outbreaks Week, December 3rd, 2002
Children who possess a gene that allows them to produce high levels of nitric oxide are protected from two of the deadliest forms of malaria, according to a published report by Maurine R. Hobbs, PhD, and Donald L. Granger, MD, at the University of Utah, Brice Weinberg, MD, Duke University, Nick Antsey, Menzies School of Health Research, Australia, and malaria experts in Atlanta, Tanzania, and Kenya.
"This is a major advance in understanding how and why children get the deadliest forms of malaria," Weinberg said in the November 9, 2002 issue of the Lancet.
The findings may lead to new treatments for more than 1 million children - most of them...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Infectious Disease Therapy
Amikacin enhances rifampin activity against Mycobacterium ulcerans - Tuberculosis Therapy
High relapse rate seen after "successful" drug-resistant TB treatment - Bacteriology
New research sheds light on bacterial firework display - Diarrhea
'Dispersin' Escherichia coli all over the gut - Infectious Disease
Virulent mycobacteria inhibit nitric oxide release, phagosome-lysosome fusion - Influenza
Hospitalized elderly patients often not vaccinated for flu, pneumonia - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
